4-[(3R)-Piperidin-3-yl]morpholin-3-one hydrochloride, 1g

2-(1-tert-Butoxycarbonylpiperazin-4-yl)acetic acid, 97.0%, 5g

4-Iodo-3,5-dimethylisoxazole, 97.0%, 1g

Unité de filtration pour centrifugeuse Ultrafree Ultrafree-MC, membrane PVDF, volume d'échantillon jusqu'à 0,5 ml, 0,22 µm, stérile, 50 pièce(s)

5-(Furan-2-yl)isoxazole, 98%, 1g

bScope BS.1153-EPLPH pour le contraste de phase. Trioculaire avec oculaires HWF 10x/20 mm et revolver quadruple E-plan Phase 10/20/S40 S100x

(3-METHYL-5-NITROPHENYL)BORONIC ACID, 95%, 100mg

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 96.0%, 100g

5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2,3-DIHYDRO-1H-INDEN-2-OL, 95%, 1g

1-Benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 5g

Molybdenum(VI) oxide, 99.5%, 500g

3-(DIMETHYLCARBAMOYL)BENZOIC ACID, 95.0%, 100mg

Ethylène Glycol, min 99%, pour synthèse, 1L, emballage plastique.